Animal Study Shows Potential for K2 in Kidney Disease

Press/Media: ResearchPopular

Description

An experimental animal model of kidney failure has shown that vitamin K2 combined with phosphate binders (PBs) could potentially be a useful therapy for chronic kidney disease (CKD) patients.
The paper was published in Nephrology, Dialysis, Transplantation, co-authored by Professor Leon Schurgers, Professor of Biochemistry of Vascular Calcification and Vice-Chair of Biochemistry at the Cardiovascular Research Institute Maastricht (CARIM), Maastricht University.

Period15 Nov 2021

Media coverage

1

Media coverage

  • TitleAnimal Study Shows Potential for K2 in Kidney Disease
    Degree of recognitionInternational
    Media name/outletWholeFoods Magazine
    Media typeOnline
    Country/TerritoryUnited States
    Date15/11/21
    DescriptionAn experimental animal model of kidney failure has shown that vitamin K2 combined with phosphate binders (PBs) could potentially be a useful therapy for chronic kidney disease (CKD) patients.
    The paper was published in Nephrology, Dialysis, Transplantation, co-authored by Professor Leon Schurgers, Professor of Biochemistry of Vascular Calcification and Vice-Chair of Biochemistry at the Cardiovascular Research Institute Maastricht (CARIM), Maastricht University.
    Producer/AuthorJulia Peterman
    URLhttps://wholefoodsmagazine.com/suppliers/news-suppliers/animal-study-shows-potential-for-k2-in-kidney-disease/
    PersonsLeon Schurgers

Keywords

  • CKD patients
  • K2 mechanism
  • absorption of dietary phosphate
  • animals
  • chronic kidney disease
  • combination
  • diet and PB treatment
  • early research
  • experimental animal model
  • findings